DE69328967T2 - Synergistische kombination einer substanz mit hemmwirkung auf die magensäuresekretion und eines säureinstabilen antibiotikums - Google Patents
Synergistische kombination einer substanz mit hemmwirkung auf die magensäuresekretion und eines säureinstabilen antibiotikumsInfo
- Publication number
- DE69328967T2 DE69328967T2 DE69328967T DE69328967T DE69328967T2 DE 69328967 T2 DE69328967 T2 DE 69328967T2 DE 69328967 T DE69328967 T DE 69328967T DE 69328967 T DE69328967 T DE 69328967T DE 69328967 T2 DE69328967 T2 DE 69328967T2
- Authority
- DE
- Germany
- Prior art keywords
- acid
- substance
- inhibitory effect
- synergistic combination
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06066—Needles, e.g. needle tip configurations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30092—Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0023—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0023—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
- A61F2210/0047—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply heated by light
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201297A SE9201297D0 (sv) | 1992-04-24 | 1992-04-24 | Synergistic combination |
SE9300029A SE9300029D0 (sv) | 1993-01-08 | 1993-01-08 | Synergistic combination ii |
PCT/SE1993/000327 WO1993021920A1 (en) | 1992-04-24 | 1993-04-20 | Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69328967D1 DE69328967D1 (de) | 2000-08-10 |
DE69328967T2 true DE69328967T2 (de) | 2000-12-07 |
Family
ID=26661401
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69328967T Revoked DE69328967T2 (de) | 1992-04-24 | 1993-04-20 | Synergistische kombination einer substanz mit hemmwirkung auf die magensäuresekretion und eines säureinstabilen antibiotikums |
DE0637241T Pending DE637241T1 (de) | 1992-04-24 | 1993-04-20 | Synergistische kombination einer substanz mit hemmwirkung auf die magensäuresekretion und eines säureinstabilen antibiotikums. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE0637241T Pending DE637241T1 (de) | 1992-04-24 | 1993-04-20 | Synergistische kombination einer substanz mit hemmwirkung auf die magensäuresekretion und eines säureinstabilen antibiotikums. |
Country Status (39)
Country | Link |
---|---|
US (3) | US5599794A (de) |
EP (2) | EP0637241B1 (de) |
JP (1) | JPH07505901A (de) |
KR (1) | KR100340165B1 (de) |
CN (1) | CN1041798C (de) |
AP (1) | AP466A (de) |
AT (1) | ATE194286T1 (de) |
AU (1) | AU669903B2 (de) |
CA (1) | CA2133762C (de) |
CZ (1) | CZ291201B6 (de) |
DE (2) | DE69328967T2 (de) |
DK (1) | DK0637241T3 (de) |
DZ (1) | DZ1683A1 (de) |
EE (1) | EE03149B1 (de) |
ES (1) | ES2100135T3 (de) |
FI (1) | FI944953A0 (de) |
GR (2) | GR970300011T1 (de) |
HK (1) | HK1008296A1 (de) |
HR (1) | HRP930755B1 (de) |
HU (1) | HUT71225A (de) |
IL (1) | IL105155A (de) |
IS (1) | IS3990A (de) |
LV (1) | LV12625B (de) |
MA (1) | MA22878A1 (de) |
MY (1) | MY121189A (de) |
NO (1) | NO314288B1 (de) |
NZ (1) | NZ252759A (de) |
PL (1) | PL173485B1 (de) |
PT (1) | PT637241E (de) |
RO (1) | RO115780B1 (de) |
RU (1) | RU2143899C1 (de) |
SG (1) | SG52485A1 (de) |
SI (1) | SI9300219B (de) |
SK (1) | SK282420B6 (de) |
TN (1) | TNSN93040A1 (de) |
TW (1) | TW276996B (de) |
UA (1) | UA43830C2 (de) |
WO (1) | WO1993021920A1 (de) |
YU (1) | YU49091B (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW420610B (en) * | 1994-04-07 | 2001-02-01 | Pfizer | A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
US6132768A (en) * | 1995-07-05 | 2000-10-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
CN1061232C (zh) * | 1996-04-12 | 2001-01-31 | 马理国 | 一种治疗胃炎、溃疡的药物组合物 |
SI9700186B (sl) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
ES2232015T3 (es) * | 1997-07-25 | 2005-05-16 | Altana Pharma Ag | Inhibidor de las bombas de protones en combinacion terapeutica con sustancias antibacterianas. |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6117868A (en) * | 1998-09-16 | 2000-09-12 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
US6852739B1 (en) * | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
WO2000050037A1 (en) * | 1999-02-26 | 2000-08-31 | Nitromed, Inc. | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US7365047B1 (en) * | 1999-09-28 | 2008-04-29 | The Regents Of The University Of California | Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
US20020004502A1 (en) * | 2000-01-05 | 2002-01-10 | Redmond H. Paul | Treatment of inflammatory bowel disease |
US6787342B2 (en) | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
KR20030047873A (ko) * | 2000-02-29 | 2003-06-18 | 테바 파마슈티컬 인더스트리즈 리미티드 | 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물 |
EP1133987A1 (de) * | 2000-03-09 | 2001-09-19 | Ian Whitcroft | Behandlung von entzündlichen Dermatosen mit Erythromycin oder Clarithromycin, Metronidazol und einem Wasserstoffpumpehemmer |
CA2413923A1 (en) * | 2000-03-09 | 2001-09-13 | Andrew Ilchyshyn | Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor |
EP1267840B1 (de) * | 2000-03-28 | 2009-06-03 | Sandoz AG | Geschmackmaskierte granulierte teilchen |
SE0002476D0 (sv) | 2000-06-30 | 2000-06-30 | Astrazeneca Ab | New compounds |
US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
WO2002026210A2 (en) * | 2000-09-29 | 2002-04-04 | Geneva Pharmaceuticals Inc. | Proton pump inhibitor formulation |
SE0103695D0 (sv) | 2001-11-07 | 2001-11-07 | Thomas Boren | A novel non-antibiotic strategy against OGIP infections based on a cereal product |
WO2003063927A2 (en) * | 2001-11-16 | 2003-08-07 | Eisai Co. Ltd | Compositions and methods to treat gastrointestinal disorders |
US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
EP1534278A4 (de) * | 2002-08-01 | 2006-09-06 | Nitromed Inc | Nitrosierte protonenpumpen-hemmer, zusammensetzungen und anwendungsverfahren |
JP2006516574A (ja) * | 2003-02-05 | 2006-07-06 | テバ ファーマシューティカル インダストリーズ リミティド | ランソプラゾール安定化方法 |
US20040248942A1 (en) * | 2003-02-20 | 2004-12-09 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US20040185092A1 (en) * | 2003-03-18 | 2004-09-23 | Yih Ming Hsiao | Pharmaceutical preparations of omeprazole and/or clarithromycin for oral use |
AR045062A1 (es) * | 2003-07-18 | 2005-10-12 | Santarus Inc | Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas |
US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
TWI337877B (en) * | 2003-07-18 | 2011-03-01 | Santarus Inc | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20060194748A1 (en) * | 2005-02-28 | 2006-08-31 | National University Corporation Nagoya University | Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same |
WO2007070164A1 (en) * | 2005-10-19 | 2007-06-21 | The Curators Of The University Of Missouri | Pharmaceutical composition comprising a proton pump inhibitor, a buffering agent and an anti-h. pylori active substance and methods of using same |
US20070141151A1 (en) * | 2005-12-20 | 2007-06-21 | Silver David I | Lansoprazole orally disintegrating tablets |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
GB2444593B (en) | 2006-10-05 | 2010-06-09 | Santarus Inc | Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations |
US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
US10869690B2 (en) * | 2017-06-29 | 2020-12-22 | Ethicon Llc | Trocar obturator with transverse needle ports |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
JP2694361B2 (ja) * | 1989-02-09 | 1997-12-24 | アストラ アクチエボラグ | 抗菌剤 |
DE69014141T2 (de) * | 1989-02-10 | 1995-05-24 | Takeda Chemical Industries Ltd | Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel. |
GB9018603D0 (en) * | 1990-08-24 | 1990-10-10 | Smith Kline French Lab | Compositions |
DE59109225D1 (de) * | 1990-09-14 | 2002-01-17 | Byk Gulden Lomberg Chem Fab | Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen |
-
1993
- 1993-03-24 IL IL10515593A patent/IL105155A/en active IP Right Review Request
- 1993-03-24 TW TW082102192A patent/TW276996B/zh active
- 1993-03-24 IS IS3990A patent/IS3990A/is unknown
- 1993-04-02 HR HR930755A patent/HRP930755B1/xx not_active IP Right Cessation
- 1993-04-07 DZ DZ930044A patent/DZ1683A1/fr active
- 1993-04-15 AP APAP/P/1993/000518A patent/AP466A/en active
- 1993-04-20 DK DK93912028T patent/DK0637241T3/da active
- 1993-04-20 PL PL93305799A patent/PL173485B1/pl unknown
- 1993-04-20 RO RO94-01707A patent/RO115780B1/ro unknown
- 1993-04-20 CZ CZ19942593A patent/CZ291201B6/cs not_active IP Right Cessation
- 1993-04-20 ES ES93912028T patent/ES2100135T3/es not_active Expired - Lifetime
- 1993-04-20 EP EP93912028A patent/EP0637241B1/de not_active Revoked
- 1993-04-20 HU HU9403069A patent/HUT71225A/hu not_active Application Discontinuation
- 1993-04-20 RU RU94045926A patent/RU2143899C1/ru not_active IP Right Cessation
- 1993-04-20 DE DE69328967T patent/DE69328967T2/de not_active Revoked
- 1993-04-20 UA UA94105962A patent/UA43830C2/uk unknown
- 1993-04-20 JP JP5519164A patent/JPH07505901A/ja active Pending
- 1993-04-20 AU AU42737/93A patent/AU669903B2/en not_active Ceased
- 1993-04-20 PT PT93912028T patent/PT637241E/pt unknown
- 1993-04-20 EP EP99108949A patent/EP0956857A3/de not_active Withdrawn
- 1993-04-20 WO PCT/SE1993/000327 patent/WO1993021920A1/en not_active Application Discontinuation
- 1993-04-20 AT AT93912028T patent/ATE194286T1/de not_active IP Right Cessation
- 1993-04-20 SG SG1996005136A patent/SG52485A1/en unknown
- 1993-04-20 SK SK1275-94A patent/SK282420B6/sk not_active IP Right Cessation
- 1993-04-20 CA CA002133762A patent/CA2133762C/en not_active Expired - Lifetime
- 1993-04-20 NZ NZ252759A patent/NZ252759A/en not_active IP Right Cessation
- 1993-04-20 DE DE0637241T patent/DE637241T1/de active Pending
- 1993-04-21 MA MA23171A patent/MA22878A1/fr unknown
- 1993-04-21 YU YU27593A patent/YU49091B/sh unknown
- 1993-04-22 US US08/051,722 patent/US5599794A/en not_active Expired - Fee Related
- 1993-04-23 MY MYPI93000749A patent/MY121189A/en unknown
- 1993-04-23 SI SI9300219A patent/SI9300219B/sl not_active IP Right Cessation
- 1993-04-23 TN TNTNSN93040A patent/TNSN93040A1/fr unknown
- 1993-04-24 CN CN93105000A patent/CN1041798C/zh not_active Expired - Fee Related
-
1994
- 1994-10-21 FI FI944953A patent/FI944953A0/fi not_active Application Discontinuation
- 1994-10-21 NO NO19944010A patent/NO314288B1/no unknown
- 1994-10-22 KR KR1019940703767A patent/KR100340165B1/ko not_active IP Right Cessation
- 1994-11-17 EE EE9400418A patent/EE03149B1/xx not_active IP Right Cessation
-
1995
- 1995-05-16 US US08/442,382 patent/US5633244A/en not_active Expired - Lifetime
- 1995-05-16 US US08/441,766 patent/US5629305A/en not_active Expired - Lifetime
-
1997
- 1997-05-30 GR GR970300011T patent/GR970300011T1/el unknown
-
1998
- 1998-07-17 HK HK98109224A patent/HK1008296A1/xx not_active IP Right Cessation
-
2000
- 2000-09-21 GR GR20000402159T patent/GR3034470T3/el not_active IP Right Cessation
- 2000-10-16 LV LVP-00-139A patent/LV12625B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69328967T2 (de) | Synergistische kombination einer substanz mit hemmwirkung auf die magensäuresekretion und eines säureinstabilen antibiotikums | |
EP0502749A3 (en) | Gate structure of field effect device and method for forming the same | |
DE69207167T2 (de) | Beutelanordnung zur Abgabe eines Produktes sowie Produktabgabevorrichtung mit einer solchen Beutelanordnung | |
KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
NO924978D0 (no) | Chinolon- og naftyridon-karboksylsyrederivater | |
DE69226460T2 (de) | Mehrkanalechokompensationsverfahren und Gerät | |
AU3462993A (en) | Remedy for dermatopathy and metallothionein inducer | |
DE69217134D1 (de) | Katheterführungsdraht und Katheter | |
FI925268A (fi) | Foerfarande och anordning att anvaendas vid oevervakning och reglering a v aotervinningsugn foer svartlut | |
DE69215396D1 (de) | Desinfektierende Kupplung für Katheter und dergleichen | |
HU00207A9 (en) | Sulfonanilide derivatives and medicine | |
DE69306768T2 (de) | Medizinischer oder veterinaerer injektionsapparat | |
DE69215608D1 (de) | Dünnschichttransistor und dessen Herstellungsmethode | |
DE3682656D1 (de) | Arzneimittel mit synergistischer entzuendungshemmender wirkung auf der basis eines corticosteroiden und eines beta-agonisten. | |
ITTO921021A0 (it) | Sistema di decollo ed atterraggio | |
AU1063892A (en) | Re-usable diaper and method | |
FI950065A (fi) | Väline lääkkeen antamiseen ja menetelmä tällaisen välineen valmistamiseksi | |
FI932747A0 (fi) | Foder och foerfarande foer optimering av effekten hos pigment i foder avsett foer laxfisk | |
EP0543268A3 (en) | Transistor device with a gate structure and method of forming the same | |
HU914067D0 (en) | New medical preparations for preventing gastric acid secretion and with gastrocitoprotective effect | |
KR930022744U (ko) | 한약재 박피기 | |
BR1100393A (pt) | Composto e formulação farmacêutica | |
BR9204830A (pt) | Válvula anti-refluxo | |
DK154891D0 (da) | Tygge- og bubblegum overtrukket med tyggegummibase | |
SE9203011D0 (sv) | Saett vid en anordning foer haallande av foeremaal samt anordning foer genomfoerande av foerfarandet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |